USFDA Concludes Inspection at Zydus Lifesciences' Ahmedabad SEZ II Facility
Zydus Lifesciences Ltd 路 Press Release 路 28 Sept 2026, 11:35 pm
USFDA Concludes Inspection at Zydus Lifesciences' Ahmedabad SEZ II Facility The USFDA conducted a current Good Manufacturing Practice (cGMP) inspection at Zydus Lifesciences' manufacturing facility located at SEZ II, Ahmedabad, from 21st Sep'26 to 28th Sep'26. The inspection concluded with a single observation, with no data integrity-related issues identified. The company stated it will work closely with the USFDA to expeditiously address the observation.
Original exchange filing (PDF)
More announcements from Zydus Lifesciences Ltd
- Press Release 路 14 Nov 2026
- Completion of transaction 路 12 Nov 2026
- Transcript of the post results earnings call held on November 4, 2026. 路 07 Nov 2026
- Press Release 路 07 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India 路 06 Nov 2026
- Investor Conference 路 06 Nov 2026
- Audio recording of the Company's Investor Call 路 05 Nov 2026
- Press Release 路 04 Nov 2026
